European journal of preventive cardiology最新文献_第4页

The association of haemoglobin A1c variability with adverse outcomes in patients with atrial fibrillation prescribed anticoagulants. 心房颤动患者血红蛋白 A1c 变异与抗凝药物不良后果的关系。

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae249

Jia-Yi Huang, An-Ping Cai, Christopher Tze Wei Tsang, Mei-Zhen Wu, Wen-Li Gu, Ran Guo, Jing-Nan Zhang, Ching-Yan Zhu, Yik-Ming Hung, Gregory Y H Lip, Kai-Hang Yiu

{"title":"The association of haemoglobin A1c variability with adverse outcomes in patients with atrial fibrillation prescribed anticoagulants.","authors":"Jia-Yi Huang, An-Ping Cai, Christopher Tze Wei Tsang, Mei-Zhen Wu, Wen-Li Gu, Ran Guo, Jing-Nan Zhang, Ching-Yan Zhu, Yik-Ming Hung, Gregory Y H Lip, Kai-Hang Yiu","doi":"10.1093/eurjpc/zwae249","DOIUrl":"10.1093/eurjpc/zwae249","url":null,"abstract":"Aims: The association of haemoglobin A1c (HbA1c) variability with the risk of adverse outcomes in patients with atrial fibrillation (AF) prescribed anticoagulants remains unclear. This study aimed to evaluate the association of HbA1c variability with the risk of ischaemic stroke (IS)/systemic embolism (SE) and all-cause mortality among patients with non-valvular AF prescribed anticoagulants.Methods and results: Patients newly diagnosed with AF from 2013 to 2018 were included. Variability in HbA1c, indexed by the coefficient of variation (CV), was determined for those with at least three HbA1c measurements available from the time of study enrolment to the end of follow-up. To evaluate whether prevalent diabetes would modify the relationship between HbA1c variability and outcomes, participants were divided into diabetes and non-diabetes groups. The study included 8790 patients (mean age 72.7% and 48.5% female). Over a median follow-up of 5.5 years (interquartile range 5.2, 5.8), the incident rate was 3.74 per 100 person-years for IS/SE and 4.89 for all-cause mortality in the diabetes group. The corresponding incident rates in the non-diabetes group were 2.41 and 2.42 per 100 person-years. In the diabetes group, after adjusting for covariates including mean HbA1c, greater HbA1c variability was significantly associated with increased risk of IS/SE [hazard ratio (HR) = 1.65, 95% confidence interval (CI): 1.27-2.13) and all-cause mortality (HR = 1.24, 95% CI: 1.05-1.47) compared with the lowest CV tertile. A similar pattern was evident in the non-diabetes group (IS/SE: HR = 1.58, 95% CI: 1.23-2.02; all-cause mortality: HR = 1.35, 95% CI: 1.10-1.64).Conclusion: Greater HbA1c variability was independently associated with increased risk of IS/SE and all-cause mortality among patients with AF, regardless of diabetic status.","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":"2073-2083"},"PeriodicalIF":8.4,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

HbA1c variability and adverse outcomes in patients treated for atrial fibrillation: beyond glycaemic control? 心房颤动患者的 HbA1c 变异与不良预后：超越血糖控制？

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae285

Laurence Salle, Federico Guerra

引用次数: 0

Ventricular arrhythmias and haemodynamic collapse during acute coronary syndrome: increased risk for sudden cardiac death? 急性冠状动脉综合征期间的室性心律失常和血流动力学衰竭--增加心脏性猝死的风险？

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae074

Minna Järvensivu-Koivunen, Juho Tynkkynen, Niku Oksala, Markku Eskola, Jussi Hernesniemi

{"title":"Ventricular arrhythmias and haemodynamic collapse during acute coronary syndrome: increased risk for sudden cardiac death?","authors":"Minna Järvensivu-Koivunen, Juho Tynkkynen, Niku Oksala, Markku Eskola, Jussi Hernesniemi","doi":"10.1093/eurjpc/zwae074","DOIUrl":"10.1093/eurjpc/zwae074","url":null,"abstract":"Aims: In the acute phase of acute coronary syndrome (ACS), ventricular tachycardia (VT) and/or ventricular fibrillation (VF) leading to resuscitation are not considered to be associated with increased long-term sudden cardiac death (SCD) because the cause-acute ischaemia-is believed to be reversible. The aim of this study is to investigate whether ventricular arrhythmias (VAs) leading to sudden cardiac arrest during ACS are associated with the risk of incident SCD in patients with a normal or mildly impaired left ventricular ejection fraction (LVEF).Methods and results: This study is based on a retrospective analysis of all 8062 consecutive ACS patients undergoing coronary angiography with the baseline LVEF ≥40% between 2007 and 2018 (follow-up until 31 December 2021). The primary outcome was SCD-equivalent life-threatening VAs (LTVAs) composed of true SCDs and SCDs aborted by successful resuscitation or appropriate implantable cardiac device (ICD) therapy. The risk of sudden LTVA was estimated with a multivariate subdistribution hazard model using other deaths as competing events. Two-hundred thirteen (n = 211, 2.6%) patients suffered acute phase VF/VT leading to resuscitation and survived to discharge, and most occurred before angiography (80.6%, n = 170) and were VF (92.9%, n = 196). During a median follow-up of 7.6 years, 3.9% (n = 316) of all the patients had LTVA (10.0% in the VF/VT group vs. 3.8% in other patients). Ventricular fibrillation/VTs during ACS are associated with an increased risk for future SCD (hazard ratio 3.07; 95% confidence interval 1.94-4.85, P < 0.001). Most LTVAs occurred in patients without ICDs.Conclusion: Ventricular fibrillation/VT in ACS is associated with a remarkably high long-term risk for SCD in patients with an LVEF ≥40%.","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":"2117-2124"},"PeriodicalIF":8.4,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139939862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Long-term rate of ventricular arrhythmia in autoimmune disease. 自身免疫性疾病的室性心律失常长期发生率

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae118

Guoli Sun, Emil L Fosbøl, Morten Schou, Mikkel Faurschou, Adelina Yafasova, Jeppe K Petersen, Ketil J Haugan, Ulrik Madvig Mogensen, Jesper H Svendsen, Lars Køber, Jawad H Butt

{"title":"Long-term rate of ventricular arrhythmia in autoimmune disease.","authors":"Guoli Sun, Emil L Fosbøl, Morten Schou, Mikkel Faurschou, Adelina Yafasova, Jeppe K Petersen, Ketil J Haugan, Ulrik Madvig Mogensen, Jesper H Svendsen, Lars Køber, Jawad H Butt","doi":"10.1093/eurjpc/zwae118","DOIUrl":"10.1093/eurjpc/zwae118","url":null,"abstract":"Aims: Although selected autoimmune diseases (AIDs) have been linked to an increased risk of ventricular arrhythmias (VAs), data on the long-term rate of VAs across the spectrum of AIDs are lacking. The aim of this study was to investigate the long-term rate of VAs (a composite of ventricular tachycardia, ventricular fibrillation, ventricular flutter, or cardiac arrest) in individuals with a history of 28 different AIDs.Methods and results: Individuals diagnosed with an AID (2005-18) were identified through Danish nationwide registries. Each patient with an AID was matched with four individuals from the background population by age and sex. Multivariable Cox regression was used to compare the rate of VAs between the AIDs and background population, overall and according to individual AIDs. In total, 186 733 patients diagnosed with AIDs were matched with 746 932 individuals without AIDs (median age 55 years; 63% female; median follow-up 6.0 years). The 5-year cumulative incidence of VAs was 0.5% for patients with AIDs and 0.3% for matched individuals. Patients with any AIDs had a higher associated rate of VAs than matched individuals {hazard ratio (HR) 1.39 [95% confidence interval (CI), 1.29-1.49]}. The highest HR was observed in patients with systemic sclerosis [3.86 (95% CI, 1.92-7.75)]. The higher rate of VAs in patients with AIDs, compared with individuals from the background population, was more pronounced in patients without ischaemic heart disease or heart failure/cardiomyopathy compared with those with these conditions (Pinteraction <0.05).Conclusion: Despite a low cumulative incidence, patients with a history of AIDs had a higher relative rate of VAs than matched individuals.","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":"2127-2134"},"PeriodicalIF":8.4,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140318098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

EJPC @ a glance: focus issue on arrhythmias-risk and prevention.

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae372

Stephan Mueller, Victor Aboyans

引用次数: 0

Rate of subsequent diagnosis of sarcoidosis after pacemaker implantation for atrioventricular block: an analysis of a nationwide epidemiological dataset. 因房室传导阻滞而植入起搏器后的肉芽肿病后续诊断率：全国流行病学数据集分析。

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae241

Toshiyuki Ko, Yuta Suzuki, Hidehiro Kaneko, Takahiro Jimba, Katsuhito Fujiu, Norifumi Takeda, Hiroyuki Morita, Hideo Yasunaga, Norihiko Takeda, Issei Komuro

引用次数: 0

Concomitant Takotsubo syndrome and stroke: two separate disorders or do they share a common aetiology? 伴发Takotsubo综合征和中风：两种不同的疾病还是有共同的病因？

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwad323

Francesco Pelliccia, Martin Hänsel, Susanne Wegener, Paolo G Camici

引用次数: 0

Novel approaches to atrial fibrillation screening: debating the clinical and practical implications. 心房颤动筛查的新方法：辩论临床和实际意义。

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae357

Hongyu Liu, Yang Chen, Gregory Y H Lip

引用次数: 0

Association of genetically predicted problem alcohol use with risk of atrial fibrillation: a Mendelian randomization study. 基因预测的问题酒精使用与心房颤动风险的关系--孟德尔随机研究。

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae211

Yuekai Ji, Lin Yee Chen, Michael J Zhang

引用次数: 0

Temporal trends in hypertension-related ischaemic stroke risk in atrial fibrillation from 2007 to 2018: a nationwide cohort study. 2007 年至 2018 年心房颤动患者高血压相关缺血性卒中风险的时间趋势：全国队列研究》。

IF 8.4 2区医学

European journal of preventive cardiology Pub Date : 2024-12-23 DOI: 10.1093/eurjpc/zwae103

Konsta Teppo, Ville Langén, K E Juhani Airaksinen, Elis Kouki, Jussi Jaakkola, Olli Halminen, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Juha Hartikainen, Mika Lehto

引用次数: 0